About beremagene gepepavec-svdt
Class: | Gene therapy product
Use: | Treatment of adult patients with dystrophic epidermolysis bullosa (DEB) due to mutations in the COL7A1 gene
Adult dose: | 5 x 10^9 PFU/ml administered as a single dose via intradermal injection
Pediatric dose: | Safety and efficacy not established in pediatric patients; use is not recommended
Side effects: | Injection site reactions (pain, erythema, swelling), fever, fatigue, headache
Contraindications: | Hypersensitivity to beremagene gepepavec-svd
Drug Class
Gene therapy product
Uses & Indications
Treatment of adult patients with dystrophic epidermolysis bullosa (DEB) due to mutations in the COL7A1 gene
Storage Requirements
Store in the original carton at -80°C to -60°C; do not freeze or thaw more than once
Manufacturer & Packaging
Manufacturer: Krystal Biotech, Inc., United States of America
Package Size
1 Kit
Price & Supplier
Price in UAE: AED 120442.50
Dosage Information
Adult Dose
5 x 10^9 PFU/ml administered as a single dose via intradermal injection
Pediatric Dose
Safety and efficacy not established in pediatric patients; use is not recommended
Side Effects
Injection site reactions (pain, erythema, swelling), fever, fatigue, headache
Contraindications & Precautions
Hypersensitivity to beremagene gepepavec-svdt or any component of the formulation
Important Warnings
Risk of severe allergic reactions; monitor for signs of hypersensitivity; not for use in patients with active infections or compromised immune systems
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice.
Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication.
The information presented here is specific to medicines available in UAE pharmacies and is regularly updated
to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.